We are live on
!
Find out more
N
NanoDimension Portfolio holdings
AUM
$24.7M
1-Year Est. Return
74.01%
This Fund
S&P 500
This Quarter
Est. Return
-25.41%
1 Year Est. Return
-74.01%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$112M
AUM Growth
–
Cap. Flow
+$133M
Cap. Flow
% of AUM
119.61%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
4
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ICVX
Icosavax, Inc. Common Stock
ICVX
|
+$71M |
| 2 |
Twist Bioscience
TWST
|
+$31.6M |
| 3 |
SQZ
SQZ Biotechnologies Company
SQZ
|
+$17.7M |
| 4 |
Cartesian Therapeutics
RNAC
|
+$13.1M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 100% |
Similar funds
AEPI
CVGI
NVPX
BAS
GX
FCMI
KL
A
NanoDimension's Q4 2021 Portfolio in Review
Q4 2021 is the first quarter with a 13F filing on record for NanoDimension, which disclosed 4 positions worth $112M. Its ten largest holdings account for 100% of the portfolio.
Its largest position is Icosavax, Inc. Common Stock: 2,749,994 shares worth $62.9M.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets.
- NanoDimension's largest Q4 2021 buy was Icosavax, Inc. Common Stock: 2,749,994 shares worth $62.9M.
- NanoDimension's ten largest holdings make up 100% of its $112M portfolio in Q4 2021.
- NanoDimension disclosed 4 positions in Q4 2021, its first 13F filing on record.
Based on NanoDimension's 13F filing for Q4 2021, filed 23 Feb 2022.